Pictet Asset Management (UK)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pictet Asset Management (UK)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$13.6M	Sell	1,058,856 -96,071	-8%	-$1.1M	0.01%	609
2021 Q1	$12.9M	Buy	1,154,927 +363,211	+46%	+$3.84M	0.02%	604
2020 Q4	$9.02M	Sell	791,716 -45,600	-5%	-$499K	0.01%	655
2020 Q3	$7.53M	Buy	837,316 +128,008	+18%	+$1.27M	0.01%	627
2020 Q2	$7.32M	Buy	709,308 +64,353	+10%	+$659K	0.01%	597
2020 Q1	$6.51M	Buy	644,955 +81,700	+15%	+$960K	0.01%	572
2019 Q4	$7.5M	Buy	+563,255	New	+$6.21M	0.01%	659
2018 Q4	–	Sell	-1,232,158	Closed	-$19.1M	–	1000
2018 Q3	$19.1M	Sell	1,232,158 -1,151,993	-48%	-$18.2M	0.04%	427
2018 Q2	$38.2M	Sell	2,384,151 -1,457,053	-38%	-$21.6M	0.09%	271
2018 Q1	$49.6M	Buy	3,841,204 +274,404	+8%	+$3.42M	0.12%	232
2017 Q4	$44.8M	Buy	3,566,800 +435,527	+14%	+$5.69M	0.12%	238
2017 Q3	$41.4M	Buy	3,131,273 +853,885	+37%	+$11.8M	0.12%	230
2017 Q2	$33.8M	Buy	2,277,388 +329,745	+17%	+$4.79M	0.1%	253
2017 Q1	$27.8M	Buy	1,947,643 +790,270	+68%	+$10.8M	0.09%	280
2016 Q4	$14.8M	Buy	1,157,373 +894,335	+340%	+$11.3M	0.06%	372
2016 Q3	$3.5M	Buy	263,038 +17,910	+7%	+$209K	0.01%	640
2016 Q2	$2.56M	Buy	245,128 +25,193	+11%	+$246K	0.01%	710
2016 Q1	$1.78M	Hold	219,935	–	–	0.01%	709
2015 Q4	$2.13M	Buy	219,935 +143,758	+189%	+$1.39M	0.01%	712
2015 Q3	$665K	Buy	+76,177	New	+$711K	﹤0.01%	814
2015 Q2	–	Sell	-247,158	Closed	-$2.83M	–	892
2015 Q1	$2.83M	Buy	+247,158	New	+$3.24M	0.01%	692
2014 Q2	–	Sell	-297,187	Closed	-$3.07M	–	882
2014 Q1	$3.07M	Sell	297,187 -27,223	-8%	-$306K	0.02%	657
2013 Q4	$3.15M	Buy	324,410 +29,253	+10%	+$263K	0.02%	639
2013 Q3	$2.93M	Buy	295,157 +24,716	+9%	+$242K	0.02%	653
2013 Q2	$2.25M	Buy	+270,441	New	+$3.28M	0.01%	687

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pictet Asset Management (UK)'s IRWD Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Ironwood Pharmaceuticals (IRWD) stake by 8.3% in Q2 2021, selling an estimated $1.1M and leaving 1,058,856 shares worth $13.6M. The position accounts for 0.01% of the portfolio, ranked #609.

Pictet Asset Management (UK) first reported a position in IRWD in Q2 2013 and has held it in 25 quarters since. The position peaked at $49.6M in Q1 2018. 209 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

Pictet Asset Management (UK) held 1,058,856 shares of Ironwood Pharmaceuticals worth $13.6M as of Q2 2021.
Pictet Asset Management (UK) sold 96,071 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $1.1M.
Ironwood Pharmaceuticals made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #609 holding.
Pictet Asset Management (UK) first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
Pictet Asset Management (UK)'s Ironwood Pharmaceuticals position peaked at $49.6M in Q1 2018.
209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.